Simultaneous analyses of hemodynamic and electrophysiological effects of oseltamivir along with its pharmacokinetic profile using the canine paroxysmal atrial fibrillation model-Reference-Cited by-同舟云学术

Simultaneous analyses of hemodynamic and electrophysiological effects of oseltamivir along with its pharmacokinetic profile using the canine paroxysmal atrial fibrillation model

Published:2022-01 Issue:1 Volume:148 Page:179-186
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Kambayashi Ryuichi,Goto Ai,Onozato Mayu,Izumi-Nakaseko Hiroko,Takei Yoshinori,Matsumoto Akio,Kawai Shinichi,Fukushima Takeshi,Sugiyama Atsushi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference31 articles.

1. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry;Chiang;Circ Arrhythm Electrophysiol,2012

2. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

3. Revisiting antiarrhythmic drug therapy for atrial fibrillation: reviewing lessons learned and redefining therapeutic paradigms;Geng;Front Pharmacol,2020

4. Atrial remodeling and atrial fibrillation: mechanisms and implications;Nattel;Circ Arrhythm Electrophysiol,2008

5. Early management of atrial fibrillation to prevent cardiovascular complications;Nattel;Eur Heart J,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: Utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fraction;Journal of Pharmacological Sciences;2024-11

2. Development and characterization of a cyclodextrin-based delivery system for enhanced pharmacokinetic and safety profile of oseltamivir;Journal of Inclusion Phenomena and Macrocyclic Chemistry;2024-09-09

3. Characterization of remodeling processes in the atria of atrioventricular block dogs: Utility as an early-stage atrial fibrillation model;Journal of Pharmacological Sciences;2024-09

4. Characterization of cardiovascular profile of anti-influenza drug peramivir: A reverse-translational study using the isoflurane-anesthetized dog;Journal of Pharmacological Sciences;2024-03